Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Research Report 2023

The global Non-alcoholic Steatohepatitis (NASH) Biomarkers market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.

North American market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

Asia-Pacific market for Non-alcoholic Steatohepatitis (NASH) Biomarkers is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.

The key global manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers include Biopredictive, Quest Diagnostics, Exalenz Bioscience, GENFIT, Siemens Healthineers, ONE WAY LIVER, Prometheus Laboratories and Gilead Sciences, etc. in 2022, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Non-alcoholic Steatohepatitis (NASH) Biomarkers, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Non-alcoholic Steatohepatitis (NASH) Biomarkers.

The Non-alcoholic Steatohepatitis (NASH) Biomarkers market size, estimations, and forecasts are provided in terms of sales volume (K Units) and revenue ($ millions), considering 2022 as the base year, with history and forecast data for the period from 2018 to 2029. This report segments the global Non-alcoholic Steatohepatitis (NASH) Biomarkers market comprehensively. Regional market sizes, concerning products by type, by application and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Non-alcoholic Steatohepatitis (NASH) Biomarkers manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by type, by application and by regions.

1.1 Product Overview and Scope of Non-alcoholic Steatohepatitis (NASH) Biomarkers

1.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Type

1.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2023-2029)

1.2.2 Serum Biomarkers

1.2.3 Cytokeratin-18 (CK 18) Marker

1.2.4 Inflammatory Markers

1.2.5 Others

1.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Segment by Application

1.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value by Application: (2023-2029)

1.3.2 Hospitals

1.3.3 Diagnostic Centers

1.3.4 Others

1.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size Estimates and Forecasts

1.4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue 2018-2029

1.4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales 2018-2029

1.4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Average Price (2018-2029)

1.5 Assumptions and Limitations

2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2018-2023)

2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Manufacturers (2018-2023)

2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price by Manufacturers (2018-2023)

2.4 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Ranking 2021 VS 2022 VS 2023

2.5 Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Manufacturing Sites & Headquarters

2.6 Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Product Type & Application

2.7 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation and Trends

2.7.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Concentration Rate

2.7.2 The Global Top 5 and Top 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players Market Share by Revenue

2.7.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3)

2.8 Manufacturers Mergers & Acquisitions, Expansion Plans

3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region: 2018 Versus 2022 Versus 2029

3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2018-2029

3.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2018-2023

3.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region: 2024-2029

3.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2018-2029

3.3.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2018-2023

3.3.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2024-2029

3.4 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.4.1 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.4.2 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2029)

3.4.3 North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2029)

3.4.4 United States

3.4.5 Canada

3.5 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.5.1 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.5.2 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2029)

3.5.3 Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2029)

3.5.4 Germany

3.5.5 France

3.5.6 U.K.

3.5.7 Italy

3.5.8 Russia

3.6 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.6.1 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.6.2 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2029)

3.6.3 Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2029)

3.6.4 China

3.6.5 Japan

3.6.6 South Korea

3.6.7 India

3.6.8 Australia

3.6.9 China Taiwan

3.6.10 Indonesia

3.6.11 Thailand

3.6.12 Malaysia

3.7 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.7.1 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.7.2 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2029)

3.7.3 Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2029)

3.7.4 Mexico

3.7.5 Brazil

3.7.6 Argentina

3.8 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Facts & Figures by Country

3.8.1 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Country: 2018 VS 2022 VS 2029

3.8.2 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2029)

3.8.3 Middle East and Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2029)

3.8.4 Turkey

3.8.5 Saudi Arabia

3.8.6 UAE

4.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2018-2029)

4.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2018-2023)

4.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Type (2024-2029)

4.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2029)

4.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2018-2029)

4.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2018-2023)

4.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Type (2024-2029)

4.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2018-2029)

4.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Type (2018-2029)

5.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2018-2029)

5.1.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2018-2023)

5.1.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Application (2024-2029)

5.1.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2018-2029)

5.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2018-2029)

5.2.1 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2018-2023)

5.2.2 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Application (2024-2029)

5.2.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2018-2029)

5.3 Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price by Application (2018-2029)

6.1 Biopredictive

6.1.1 Biopredictive Corporation Information

6.1.2 Biopredictive Description and Business Overview

6.1.3 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.1.4 Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.1.5 Biopredictive Recent Developments/Updates

6.2 Quest Diagnostics

6.2.1 Quest Diagnostics Corporation Information

6.2.2 Quest Diagnostics Description and Business Overview

6.2.3 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.2.4 Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.2.5 Quest Diagnostics Recent Developments/Updates

6.3 Exalenz Bioscience

6.3.1 Exalenz Bioscience Corporation Information

6.3.2 Exalenz Bioscience Description and Business Overview

6.3.3 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.3.4 Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.3.5 Exalenz Bioscience Recent Developments/Updates

6.4 GENFIT

6.4.1 GENFIT Corporation Information

6.4.2 GENFIT Description and Business Overview

6.4.3 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.4.4 GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.4.5 GENFIT Recent Developments/Updates

6.5 Siemens Healthineers

6.5.1 Siemens Healthineers Corporation Information

6.5.2 Siemens Healthineers Description and Business Overview

6.5.3 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.5.4 Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.5.5 Siemens Healthineers Recent Developments/Updates

6.6 ONE WAY LIVER

6.6.1 ONE WAY LIVER Corporation Information

6.6.2 ONE WAY LIVER Description and Business Overview

6.6.3 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.6.4 ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.6.5 ONE WAY LIVER Recent Developments/Updates

6.7 Prometheus Laboratories

6.6.1 Prometheus Laboratories Corporation Information

6.6.2 Prometheus Laboratories Description and Business Overview

6.6.3 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.4.4 Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.7.5 Prometheus Laboratories Recent Developments/Updates

6.8 Gilead Sciences

6.8.1 Gilead Sciences Corporation Information

6.8.2 Gilead Sciences Description and Business Overview

6.8.3 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales, Revenue and Gross Margin (2018-2023)

6.8.4 Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product Portfolio

6.8.5 Gilead Sciences Recent Developments/Updates

7.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Chain Analysis

7.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Key Raw Materials

7.2.1 Key Raw Materials

7.2.2 Raw Materials Key Suppliers

7.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Mode & Process

7.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales and Marketing

7.4.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Channels

7.4.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors

7.5 Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers

8.1 Non-alcoholic Steatohepatitis (NASH) Biomarkers Industry Trends

8.2 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers

8.3 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges

8.4 Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

10.1 Methodology/Research Approach

10.1.1 Research Programs/Design

10.1.2 Market Size Estimation

10.1.3 Market Breakdown and Data Triangulation

10.2 Data Source

10.2.1 Secondary Sources

10.2.2 Primary Sources

10.3 Author List

10.4 Disclaimer

List of Tables

    Table 1. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)

    Table 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)

    Table 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Competitive Situation by Manufacturers in 2022

    Table 4. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) of Key Manufacturers (2018-2023)

    Table 5. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Manufacturers (2018-2023)

    Table 6. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Manufacturers (2018-2023)

    Table 7. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers (2018-2023)

    Table 8. Global Market Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) of Key Manufacturers (2018-2023)

    Table 9. Global Key Players of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Industry Ranking, 2021 VS 2022 VS 2023

    Table 10. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Manufacturing Sites & Headquarters

    Table 11. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Product Type & Application

    Table 12. Global Key Manufacturers of Non-alcoholic Steatohepatitis (NASH) Biomarkers, Date of Enter into This Industry

    Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)

    Table 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-alcoholic Steatohepatitis (NASH) Biomarkers as of 2022)

    Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans

    Table 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Table 17. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2018-2023) & (K Units)

    Table 18. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2018-2023)

    Table 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2024-2029) & (K Units)

    Table 20. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2024-2029)

    Table 21. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2018-2023) & (US$ Million)

    Table 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2018-2023)

    Table 23. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2024-2029) & (US$ Million)

    Table 24. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2024-2029)

    Table 25. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 26. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023) & (K Units)

    Table 27. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2024-2029) & (K Units)

    Table 28. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 29. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 30. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 31. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023) & (K Units)

    Table 32. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2024-2029) & (K Units)

    Table 33. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 34. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 35. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)

    Table 36. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2018-2023) & (K Units)

    Table 37. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Region (2024-2029) & (K Units)

    Table 38. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2018-2023) & (US$ Million)

    Table 39. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Region (2024-2029) & (US$ Million)

    Table 40. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 41. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023) & (K Units)

    Table 42. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2024-2029) & (K Units)

    Table 43. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 44. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 45. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)

    Table 46. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2018-2023) & (K Units)

    Table 47. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales by Country (2024-2029) & (K Units)

    Table 48. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2018-2023) & (US$ Million)

    Table 49. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue by Country (2024-2029) & (US$ Million)

    Table 50. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2018-2023)

    Table 51. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Type (2024-2029)

    Table 52. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2018-2023)

    Table 53. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Type (2024-2029)

    Table 54. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Type (2018-2023)

    Table 55. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Type (2024-2029)

    Table 56. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2018-2023)

    Table 57. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Type (2024-2029)

    Table 58. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2018-2023)

    Table 59. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2024-2029)

    Table 60. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2018-2023)

    Table 61. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units) by Application (2024-2029)

    Table 62. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2018-2023)

    Table 63. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Application (2024-2029)

    Table 64. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Application (2018-2023)

    Table 65. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue (US$ Million) by Application (2024-2029)

    Table 66. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2018-2023)

    Table 67. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Application (2024-2029)

    Table 68. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2018-2023)

    Table 69. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2024-2029)

    Table 70. Biopredictive Corporation Information

    Table 71. Biopredictive Description and Business Overview

    Table 72. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 73. Biopredictive Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 74. Biopredictive Recent Developments/Updates

    Table 75. Quest Diagnostics Corporation Information

    Table 76. Quest Diagnostics Description and Business Overview

    Table 77. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 78. Quest Diagnostics Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 79. Quest Diagnostics Recent Developments/Updates

    Table 80. Exalenz Bioscience Corporation Information

    Table 81. Exalenz Bioscience Description and Business Overview

    Table 82. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 83. Exalenz Bioscience Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 84. Exalenz Bioscience Recent Developments/Updates

    Table 85. GENFIT Corporation Information

    Table 86. GENFIT Description and Business Overview

    Table 87. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 88. GENFIT Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 89. GENFIT Recent Developments/Updates

    Table 90. Siemens Healthineers Corporation Information

    Table 91. Siemens Healthineers Description and Business Overview

    Table 92. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 93. Siemens Healthineers Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 94. Siemens Healthineers Recent Developments/Updates

    Table 95. ONE WAY LIVER Corporation Information

    Table 96. ONE WAY LIVER Description and Business Overview

    Table 97. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 98. ONE WAY LIVER Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 99. ONE WAY LIVER Recent Developments/Updates

    Table 100. Prometheus Laboratories Corporation Information

    Table 101. Prometheus Laboratories Description and Business Overview

    Table 102. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 103. Prometheus Laboratories Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 104. Prometheus Laboratories Recent Developments/Updates

    Table 105. Gilead Sciences Corporation Information

    Table 106. Gilead Sciences Description and Business Overview

    Table 107. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)

    Table 108. Gilead Sciences Non-alcoholic Steatohepatitis (NASH) Biomarkers Product

    Table 109. Gilead Sciences Recent Developments/Updates

    Table 110. Key Raw Materials Lists

    Table 111. Raw Materials Key Suppliers Lists

    Table 112. Non-alcoholic Steatohepatitis (NASH) Biomarkers Distributors List

    Table 113. Non-alcoholic Steatohepatitis (NASH) Biomarkers Customers List

    Table 114. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Trends

    Table 115. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Drivers

    Table 116. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Challenges

    Table 117. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Restraints

    Table 118. Research Programs/Design for This Report

    Table 119. Key Data Information from Secondary Sources

    Table 120. Key Data Information from Primary Sources

List of Figures

    Figure 1. Product Picture of Non-alcoholic Steatohepatitis (NASH) Biomarkers

    Figure 2. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Type (2023-2029) & (US$ Million)

    Figure 3. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Type in 2022 & 2029

    Figure 4. Serum Biomarkers Product Picture

    Figure 5. Cytokeratin-18 (CK 18) Marker Product Picture

    Figure 6. Inflammatory Markers Product Picture

    Figure 7. Others Product Picture

    Figure 8. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Value Comparison by Application (2023-2029) & (US$ Million)

    Figure 9. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Application in 2022 & 2029

    Figure 10. Hospitals

    Figure 11. Diagnostic Centers

    Figure 12. Others

    Figure 13. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue, (US$ Million), 2018 VS 2022 VS 2029

    Figure 14. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size (2018-2029) & (US$ Million)

    Figure 15. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales (2018-2029) & (K Units)

    Figure 16. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Average Price (US$/Unit) & (2018-2029)

    Figure 17. Non-alcoholic Steatohepatitis (NASH) Biomarkers Report Years Considered

    Figure 18. Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Share by Manufacturers in 2022

    Figure 19. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Share by Manufacturers in 2022

    Figure 20. The Global 5 and 10 Largest Non-alcoholic Steatohepatitis (NASH) Biomarkers Players: Market Share by Revenue in 2022

    Figure 21. Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022

    Figure 22. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Market Size by Region (US$ Million): 2018 VS 2022 VS 2029

    Figure 23. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2018-2029)

    Figure 24. North America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 25. United States Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 26. Canada Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 27. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2018-2029)

    Figure 28. Europe Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 29. Germany Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 30. France Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 31. U.K. Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 32. Italy Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 33. Russia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 34. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Region (2018-2029)

    Figure 35. Asia Pacific Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Region (2018-2029)

    Figure 36. China Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 37. Japan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 38. South Korea Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 39. India Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 40. Australia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 41. China Taiwan Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 42. Indonesia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 43. Thailand Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 44. Malaysia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 45. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2018-2029)

    Figure 46. Latin America Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 47. Mexico Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 48. Brazil Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 49. Argentina Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 50. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Sales Market Share by Country (2018-2029)

    Figure 51. Middle East & Africa Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Market Share by Country (2018-2029)

    Figure 52. Turkey Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 53. Saudi Arabia Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 54. UAE Non-alcoholic Steatohepatitis (NASH) Biomarkers Revenue Growth Rate (2018-2029) & (US$ Million)

    Figure 55. Global Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2018-2029)

    Figure 56. Global Revenue Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Type (2018-2029)

    Figure 57. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Type (2018-2029)

    Figure 58. Global Sales Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2018-2029)

    Figure 59. Global Revenue Market Share of Non-alcoholic Steatohepatitis (NASH) Biomarkers by Application (2018-2029)

    Figure 60. Global Non-alcoholic Steatohepatitis (NASH) Biomarkers Price (US$/Unit) by Application (2018-2029)

    Figure 61. Non-alcoholic Steatohepatitis (NASH) Biomarkers Value Chain

    Figure 62. Non-alcoholic Steatohepatitis (NASH) Biomarkers Production Process

    Figure 63. Channels of Distribution (Direct Vs Distribution)

    Figure 64. Distributors Profiles

    Figure 65. Bottom-up and Top-down Approaches for This Report

    Figure 66. Data Triangulation

    Figure 67. Key Executives Interviewed